Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Liver enzymes: No trivial elevations, even if asymptomatic

Brian Agganis, MD, David Lee, MD and Thomas Sepe, MD
Cleveland Clinic Journal of Medicine August 2018, 85 (8) 612-617; DOI: https://doi.org/10.3949/ccjm.85a.17103
Brian Agganis
Department of Internal Medicine, Brown University, Providence, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
David Lee
Department of Internal Medicine, Brown University, Providence, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Sepe
Department of Gastroenterology, Brown University, Providence, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Liver disease and associated liver enzyme elevations

    Hepatocellular disease
    (aminotransferase elevations predominate)
    Common
     Alcoholic liver disease
     Autoimmune hepatitis
     Chronic viral hepatitis
     Genetic hemochromatosis (northern European ethnicity)
     Medication toxicity (see Table 2)
     Nonalcoholic fatty liver disease
    Less common
     Alpha-1 antitrypsin deficiency
     Wilson disease
    Cholestatic disease
    (alkaline phosphatase, bilirubin, and gammaglutamyl transferase elevations predominate)
    Common
     Biliary obstruction (eg, gallstones)
     Drug hepatotoxicity
     Neoplasm
     Primary biliary cirrhosis
     Primary sclerosing cholangitis
    Less common
     Autoimmune cholangiopathy
     Sarcoidosis
    • From Aragon G, Zounossi ZM. When and how to evaluate mildly elevated liver enzymes in apparently healthy patients. Cleve Clin J Med 2010; 77(3):195–204. doi:10.3949/ccjm.77a.09064.

    • View popup
    TABLE 2

    Hepatotoxicity of selected drugs

    Hepatocellular abnormalities
    Acetaminophen—acute hepatitis
    Allopurinol—granuloma
    Azathioprine—veno-occlusive disease, nodular regenerative hyperplasia
    Chaparral—portal inflammation with bile duct proliferation, lobar necrosis, and collapse
    Diclofenac, other nonsteroidal anti-inflammatory drugs
    Hydralazine—granuloma
    Isoniazid
    Methotrexate—fibrosis
    Methyldopa
    Mistletoe—hepatocellular injury
    Nitrofurantoin—autoimmune-like disease
    Quinidine—granuloma
    Statins
    Toxic alkaloid—veno-occlusive disease
    Cholestatic abnormalities
    Amoxicillin-clavulanate, other penicillin derivatives
    Anabolic steroids—cholestasis, peliosis hepatis, neoplasm
    Captopril
    Carbamazepine
    Chlorpromazine
    Erythromycin estolate
    Estrogens
    Kava—hepatic necrosis, cholestasis, lobular hepatitis Oral contraceptives
    Phenytoin—mononucleosis-like syndrome
    Sulfa drugs
    Drug-induced fatty liver
    (with or without hepatocellular abnormalities)
    Amiodarone —phospholipidosis
    Anabolic steroids—cholestasis, peliosis hepatis, neoplasm
    Cocaine—microvesicular steatosis
    Corticosteroids
    Jin Bu Huan—focal hepatic necrosis, steatosis, bridging fibrosis
    Tetracycline
    Valproic acid
    • Adapted from Aragon G, Zounossi ZM. When and how to evaluate mildly elevated liver enzymes in apparently healthy patients. Cleve Clin J Med 2010; 77(3):195–204. doi:10.3949/ccjm.77a.09064.

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 85 (8)
Cleveland Clinic Journal of Medicine
Vol. 85, Issue 8
1 Aug 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Liver enzymes: No trivial elevations, even if asymptomatic
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Liver enzymes: No trivial elevations, even if asymptomatic
Brian Agganis, David Lee, Thomas Sepe
Cleveland Clinic Journal of Medicine Aug 2018, 85 (8) 612-617; DOI: 10.3949/ccjm.85a.17103

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Liver enzymes: No trivial elevations, even if asymptomatic
Brian Agganis, David Lee, Thomas Sepe
Cleveland Clinic Journal of Medicine Aug 2018, 85 (8) 612-617; DOI: 10.3949/ccjm.85a.17103
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • PATTERN OF ELEVATION: CHOLESTATIC OR HEPATOCELLULAR
    • HOW SHOULD ABNORMAL RESULTS BE EVALUATED?
    • FATTY LIVER
    • OTHER DISORDERS OF LIVER FUNCTION
    • REFERRAL
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • The bias of word choice and the interpretation of laboratory tests
  • Liver enzymes, August 2018
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
  • Managing right ventricular failure in the setting of pulmonary embolism
  • Psychedelics, spirituality, and existential distress in patients at the end of life
Show more Review

Similar Articles

Subjects

  • Hepatology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire